Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
OBI-902, targeting TROP2, gains FDA orphan drug status for cholangiocarcinoma, a rare cancer with poor prognosis and limited treatments. Orphan drug designation provides benefits like tax credits and ...
A local waste and pollution watchdog urged the Food and Drug Administration (FDA) to analyze colored sand play products being sold in the market after the regulatory authorities in Australia and New ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
RespireRx Pharmaceuticals Inc. ('RespireRx” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...
Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial ...
RespireRx Pharmaceuticals Inc. ('RespireRx”, 'RSPI”, 'Respondent” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by ...
Q3 2025 Earnings Call Transcript November 13, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.19, ...
Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ ...
Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM ESTCompany ParticipantsUdit Batra - President, CEO ...
Stockhead on MSN
The art of the health deal: How strong data opens doors
Strong clinical data doesn’t just move share prices – it can unlock lucrative global licensing deals for ASX-listed healthcare companies. ... Read More The post The art of the health deal: How strong ...
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback